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Abstract
PURPOSE: Enhancing Standard Cardiac Rehabilitation with Stress Management Training in
Patients with Heart Disease (ENHANCED) is a randomized clinical trial (RCT) funded by the
NHLBI to evaluate the effects of stress management training (SMT) on changes in biomarkers of
risk and quality of life for patients enrolled in traditional exercise-based cardiac rehabilitation
(CR).
METHODS: One hundred fifty cardiac patients recruited from Duke University and the
University of North Carolina will be evaluated and randomized to CR enhanced by SMT
(including sessions devoted to relaxation training, cognitive restructuring, communication skills,
and problem solving) or to standard exercise-based CR. Before and following 12 weeks of
treatment, patients will undergo a battery of psychometric questionnaires and evaluation of
cardiovascular biomarkers including measures of flow-mediated dilation, heart rate variability,
baroreflex sensitivity, platelet function and inflammation, and ischemia during laboratory mental
stress testing. The primary outcomes include a composite measure of stress (distress, depression,
anxiety, and hostility and 24-hr urinary catecholamines and cortisol) and a composite measure of
cardiac biomarkers of risk (vascular endothelial function, cardiac vagal control, inflammation,
platelet function and mental stress-induced myocardial ischemia). Secondary outcomes include
measures of quality of life as well as clinical events including death, hospitalizations, myocardial
infarction, and revascularization procedures.
RESULTS: This article reviews prior studies in the area and describes the design of the
ENHANCED study. Several key methodological issues are discussed including the assessment of
biomarkers of risk and barriers to the integration of SMT into traditional CR.
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CONCLUSIONS: The ENHANCED study will provide important information by determining
the extent to which SMT combined with exercise-based CR may improve prognosis and quality of
life in vulnerable cardiac patients.
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Coronary heart disease (CHD) is the leading cause of death in the United States, affecting 1
million people each year. In 2004, 871,500 people died of CHD, accounting for 36% of all
U.S. deaths.1 We now know that traditional risk factors (eg, cigarette smoking,
hyperlipidemia, diabetes, hypertension) do not fully account for the timing and occurrence
of CHD events, and it is widely recognized that stress and negative emotions affect the
development and course of CHD.2-4 For example, in the INTERHEART study, a composite
“stress” index score was shown to have an odds ratio of 2.67 adjusted for all other risk
factors, which was comparable to the “traditional” risk factors.5-6 Psychological risk factors
such as hostility have been shown to predispose individuals to the occurrence of myocardial
ischemia7 and anger has been shown to be a trigger for acute myocardial infarction (MI)8-9
and myocardial ischemia.10 There is even stronger evidence that clinical depression is
associated with increased risk for fatal and non-fatal CHD events among both healthy
persons and cardiac patients.11 Meta-analytic studies have suggested that depressive
symptoms are associated with a mortality odds ratio of 2.24.12 Importantly, even depressive
symptoms that do not meet formal DSM-IV criteria for MDD have been associated with
increased risk among CHD patients.13 Other studies have shown that acute stress from major
catastrophic events such as war14 and earthquakes,15 as well as stress at work,16 chronic
anxiety and panic attacks17-19 can also trigger CHD events.
This evidence has also provided the rationale for developing interventional strategies to
reduce stress in susceptible individuals in order to modify the natural history of these
clinical events. Indeed, there are now promising data to suggest that stress management
training (SMT) is one such approach, and that SMT can have beneficial effects on
psychosocial and medical outcomes.3 However, many of the randomized clinical trials
(RCTs) employing stress management approaches in CHD patients have had important
methodological limitations and several of the larger RCTs have failed to demonstrate a
benefit for SMT over usual care,20-21 raising questions about the value of SMT for patients
with CHD. Moreover, selecting appropriate endpoints for SMT interventions has proven to
be highly challenging for clinical investigators. Reliance on “hard” clinical endpoints is
problematic because studies require such large sample sizes that they are logistically
difficult to conduct and are prohibitively expensive. The use of intermediate
pathophysiologic endpoints that have been shown to be independently associated with
increased risk represents a novel and exciting opportunity to study the benefits of SMT on
meaningful biomedical outcomes that could provide a basis for larger RCTs. The
ENHANCED study was developed in response to a Program Announcement (PA-07-322)
inviting proposals to assess the efficacy of stress management compared to usual care in
improving intermediate outcomes relevant to mental stress influences on major cardiac
events in patients with coronary heart disease (CHD). We believe that the context of cardiac
rehabilitation (CR) is an ideal setting in which to examine this issue.
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EXERCISE AND STRESS MANAGEMENT INTERVENTIONS IN CARDIAC
REHABILITATION
Exercise-based Cardiac Rehabilitation
The US Public Health Service defines cardiac rehabilitation services as “comprehensive,
long term programs involving medical evaluation, prescribed exercise, cardiac risk factor
modification, education, and counseling”.22 Currently, exercise-based CR, involving 12-
weeks/36 sessions of aerobic exercise supplemented with resistance training is the primary
treatment for most CR programs in the United States.23 Proper medical management is also
emphasized, along with weight loss and nutrition, and smoking cessation.24 Although no
single study has demonstrated definitively that exercise reduces morbidity in patients with
CHD, pooling data across clinical trials has shown that exercise may reduce risk of fatal
CHD events by 25%.22,25-26 The Clinical Practice Guidelines for Cardiac Rehabilitation22
provided a comprehensive review of the literature and confirmed the value of exercise
training in cardiac patients for improving a number of clinical endpoints, including survival.
In contrast, the Health Care Bulletin on Cardiac Rehabilitation27 concluded that “exercise
improves physical aspects of recovery at no additional risk, but as a sole intervention it is
not sufficient to reduce risk factors, morbidity, or mortality.” These conclusions are different
from prior reviews25-26 that suggested that there was no difference in outcomes comparing
exercise alone or in combination with other behavioral interventions. Because previous
studies cited in the meta-analyses were small, methodologically flawed, and often limited to
primarily low-risk, middle-aged post-MI men, with few women, minorities, or other cardiac
patient groups the clinical value of exercise as a sole treatment for cardiac patients remains
ambiguous. A recent, comprehensive meta-analysis by Jolliffe et al28 reported a 27%
reduction in all cause mortality for exercise only, but surprisingly only a 13% reduction for
“comprehensive” CR. Cardiac mortality was reduced by 31% in the exercise only and 26%
in comprehensive CR when compared to usual care. As a result, Jolliffe et al28 concluded
that exercise-based CR was effective in reducing cardiac deaths, but that it was unclear if
exercise only or if a comprehensive CR program was more beneficial. As such, there is no
consensus on whether traditional exercise-based CR is an effective “stand-alone” treatment
for cardiac problems.
Stress Management Training in CHD Patients
It is widely believed that psychosocial interventions can benefit patients with CHD.4, 29-31
Studies have shown that psychosocial interventions are associated with reduced rates of
rehospitalization,32 cardiac death,33 total cardiac events,31 and improved risk factor
modification.32,34 In a partially randomized trial, Friedman et al35 reported that the nonfatal
reinfarction rate was 12.9% among the 592 patients receiving Type A modification
compared to 21.2% among 270 controls who only received cardiologic counseling after 4.5
years. Several reviews have provided very optimistic assessments of the value of SMT in
cardiac patients. For example, Linden et al29 compared 2024 patients who received
psychosocial interventions and 1156 control subjects who received standard medical therapy
and usually some form of exercise training. Relative to controls, psychosocially treated
patients showed greater reductions in psychological distress, but also in lower blood
pressure, heart rate, and cholesterol levels. Patients who received psychosocial interventions
were over 40% less likely to die and were 65% less likely to have a recurrent coronary event
than controls over a 2 year follow-up period. In a recent review, Rees et al20 aggregated
findings from 18 studies in which 5242 patients were randomized. Although there was
limited support for the benefits of stress management on total mortality in the 10 trials that
reported death as an outcome (OR = 0.9; 95%CI 0.7-1.2) and on cardiac mortality in 4
studies (OR = 0.6; 95%CI 0.4-0.99), there was evidence of a significant reduction in
nonfatal MI compared to controls (OR = 0.7; 95%CI 0.5-0.9) in 8 studies.
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To date, we are not aware of any RCTs that have evaluated the added benefit of combining
traditional exercise-based CR and SMT. A prior study conducted at Duke found that SMT
reduced the occurrence of myocardial ischemia in the laboratory and during daily life and
was also associated with better clinical outcomes compared to usual care.36-37 Compared to
the usual care group, the relative risk of an event after adjusting for baseline risk factors was
0.26 for the SMT group and 0.68 for the exercise group. Thus, the SMT intervention not
only modified psychological outcomes, but also had a significant impact on longer-term
clinical outcomes.36 Moreover, a subsequent 5-year follow-up revealed that patients who
underwent stress management continued to exhibit improved clinical outcomes over the
follow-up period compared to both the exercise training and usual medical care control
groups and had lower health care costs compared to the other groups.37 However, these
results were considered inconclusive because the usual care control patients were not
randomized.
We conducted a subsequent study that employed a fully randomized design including a
usual care control group, but exercise and SMT were delivered separately.38 Patients in both
active treatment groups exhibited reductions in depression and distress compared to usual
care controls. Patients in both active treatment groups also exhibited smaller reductions in
left ventricular ejection fraction during mental stress testing, and greater improvements in a
variety of cardiovascular “biomarkers” including flow mediated dilation and baroreflex
sensitivity. Interestingly, SMT patients also exhibited greater improvements in heart rate
variability compared to exercisers and usual care controls, suggesting the potential added
value of combining SMT with exercise training in CHD patients. While the benefits of SMT
were confirmed, the design did not address the question of the added value of combining
SMT with exercise. This issue is critically important because while exercise is a critical
component of most CR programs, it is not known if SMT can add to the benefits of
traditional exercise-based CR. Currently, SMT in cardiac rehabilitation programs provide
education about the importance of stress and relaxation techniques; however, more intensive
techniques such as problem-solving and cognitive restructuring are not typically provided or
integrated into daily life.
Another important methodological challenge in evaluating the usefulness of SMT has been
selecting appropriate endpoints for SMT interventions. The use of intermediate
pathophysiologic endpoints shown to be independently associated with increased cardiac
risk provides an innovative way to evaluate the benefits of SMT on meaningful biomedical
outcomes for vulnerable cardiac patients. Thus, we believe that a randomized control trial is
warranted to (1) assess the extent to which combining exercise-based CR and SMT is more
effective at improving biomarkers in vulnerable CHD patients compared to CR alone and (2)
to test the hypothesis that reductions in stress will mediate the relationship between SMT
and improvements in biomarkers.
METHODS
The Enhancing Standard Cardiac Rehabilitation with Stress Management Training in
Patients with Heart Disease (ENHANCED) study is an RCT in which 150 men and women
with CHD will be randomly assigned to 1 of 2 conditions: 1) exercise-based CR or 2) SMT-
enhanced exercise-based CR. Participants will undergo assessments of cardiovascular
biomarkers at baseline and complete psychosocial assessments, which will be repeated after
completion of the 12-week intervention. Randomization of patients will proceed using a
conditionally random assignment plan, with assignment conditional upon gender, age (<60
or ≥ 60), stress level (General Health Questionnaire [GHQ] <5 or ≥ 5), and left ventricular
ejection fraction (LVEF) (<40% or ≥ 40%). Our protocol was approved by the National
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Institutes of Health and by the Institutional Review Boards at Duke University and the
University of North Carolina.
Participant Eligibility
The ENHANCED study will involve patients recruited at Duke University and University of
North Carolina – Chapel Hill (UNC). Sample size was chosen to ensure adequate power to
compare the effects of SMT-enhanced CR versus standard CR on our primary (ie,
intermediate biomarkers of cardiovascular risk and measures of stress) and secondary
endpoints (ie, death or first cardiac-related hospitalization). We plan to recruit 35% female
and 25% minority patients for this study to improve upon the generalizability of previous
studies. Male or female outpatients ≥35 years of age with a documented history of CHD
who are eligible for cardiac rehabilitation in North Carolina, have capacity to provide
informed consent and follow study procedures will be included in the study. Patients who
have received a heart transplant or valvular repair, LVEF < 30%, labile ECG changes prior
to testing, current use of a pacemaker, resting BP >200/120mm Hg, left main disease >50%,
or are unable or unwilling to comply with assessment procedures or to be randomized into
treatment groups will be excluded.
Interventions
Standard cardiac rehabilitation—The CR programs at Duke and UNC, like most
programs in US, are primarily exercised-based with modest attention to nutritional factors,
medication adherence, and psychosocial issues. Patients exercise 3 times a week for 3
months at a level of 70-85% of their initial peak heart rate reserve or at their maximum heart
rate without pain, or ST-segment depression >2 mm, as determined at the time of their initial
exercise treadmill test. Exercise consists of 10 minutes of warm-up exercises followed by
30-35 minutes of continuous walking, biking, or jogging under medical supervision. Patients
also receive several classes in nutrition based upon the standard American Heart Association
(AHA) guidelines39 and 2 classes devoted to the role of stress in heart disease. Stress
management training is not provided to most patients, and while a few patients may be
referred for more intensive treatment (<5%), even fewer patients actually receive mental
health services.
SMT-enhanced cardiac rehabilitation: Combining standard CR and SMT—
Patients in this condition will receive the identical standard CR intervention plus SMT. SMT
is based upon our previous intervention studies36,38 that use a cognitive-social learning
model of behavior and successfully reduced ischemic activity and improved psychological
functioning. The intervention is delivered in a group, and focuses on the dynamic interaction
of the social environment with personality traits that predispose the individual to respond in
particular ways. There will be twelve 1.5-hour sessions in the treatment module. Treatment
methods include lectures, demonstrations, readings, and weekly assignments of behavioral
drills between sessions.
Ongoing medical care—All patients, including those in the SMT condition, will receive
CR and will continue with their regular medical care. This care includes the provision of
educational information about CHD and its treatment. All patients will be followed by their
cardiologists who, in an ongoing fashion, will manage any episodes of escalating symptoms
or disease progression.
Assessments
Patients will be assessed at baseline and after 3 months of treatment. Psychosocial
measurements of stress will include self-report questionnaires of somatic symptoms, health
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behaviors, physical activity, depression, anxiety, hostility, social support, quality of life,
coping, and quality of marriage. Physiological biomarkers will assess for cardiovascular risk
factors in each patient.
Measures of Stress and Health Behaviors—In order to assess stress levels and
relevant health behaviors, participants will complete a battery of psychometric tests
including the (GHQ),40 the Beck Depression Inventory (BDI),41 the state and trait anxiety
versions of the State-Trait Anxiety Inventory (STAI),42 and the Cook-Medley Hostility (Ho)
Scale.43 We also will assess medication adherence using the Brief Medication
Questionnaire,44 dietary habits using a 7-day retrospective food frequency questionnaire,45
and physical activity using the CHAMPS Activities Questionnaire.46 Because SMT consists
of a number of components (eg, progressive muscle relaxation, coping skills training,
communication skills, problem solving, etc.), we also will examine the ingredients of SMT
in order to document the effectiveness of the SMT intervention and provide insights into the
active components of SMT that could be responsible for observed improvements in the
outcomes. For example, because improved coping is believed to be one mechanism
responsible for reduced distress, we will be evaluating coping strategies using the Brief
Cope questionnaire47 and we also will administer the Dysfunctional Attitudes Scale48 to
provide an additional indicator of participant use of negative cognitive processing in
approaching life problems. We also will assess social support with the Perceived Social
Support Scale (PSSS).49
Cardiovascular Biomarkers of Risk
Flow-mediated dilation (FMD): Assessment of endothelial function—Our
technique for assessing flow-mediated dilation (FMD) follows procedures first described by
Celermajer et al50 and conforms to current standards established by committee guidelines
published in 2002.51 Longitudinal B-mode ultrasound images of the brachial artery will be
acquired using a high-frequency transducer at baseline and during reactive hyperemia
induced by 5 minutes of forearm occlusion. FMD will be calculated as the maximum percent
change in arterial diameter relative to pre-inflation baseline.
Baroreceptor reflex sensitivity (BRS) and heart rate variability (HRV): Indices
of cardiac vagal control—A Finapres noninvasive blood pressure monitor (Ohmeda,
Madison, WI) will be used for beat-to-beat blood pressure assessment.51 During the last 10
minutes of a 20 minute resting period, continuous beat-to-beat blood pressure and R-R
interval measurements will be recorded for noninvasive assessment of BRS and HRV.
Measures of platelet activation, chronic inflammation, and stress hormones—
Morning blood samples will be obtained for measurement of platelet activation and
aggregability, and biomarkers of inflammation. Participants also will collect 24-hour urine
specimens for measurements of norepinephrine, epinephrine, and free cortisol excretion.
Physiological responses to mental stress—Laboratory stressors have been shown to
elicit episodes of transient myocardial ischemia in susceptible individuals,53-54 and stress-
induced ischemia is associated with an increased risk of adverse events.55-58 Participants
will undergo a standardized laboratory mental stress procedure with simultaneous
echocardiographic monitoring for ischemia. The stressor will consist of preparation and
delivery of a speech about a current events topic. During the speech, standard 2-dimentional
ultrasound images of the left ventricle will be acquired for subsequent off-line analysis by an
experienced echocardiographer who is blinded to treatment group and other patient data.
Regional left ventricular wall motion will be assessed using a 16-segment model.59 The
motion of each segment will be graded on a scale from 0 to 3 and a wall motion score index
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(WMSI) will be calculated as the sum of scores divided by the number of segments
visualized as described by Gottdiener et al.60
Statistical Analysis
Treatment effect on primary outcomes—The initial test will be of the treatment
effects on the primary endpoints: stress and biomarkers of cardiovascular risk. For this
analysis we will use the procedure for multiple endpoints recommended by O'Brien61 and
follow the intent to treat principle. We will create separate global scores for the stress
(general distress (GHQ), depression (BDI), anxiety (STAI), anger (Ho), and 24-hour urinary
epinephrine and cortisol) and biomarker measures (FMD, BRS, CRP, LTA, and mental
stress-induced myocardial ischemia). We also will explore the extent to which the treatment
might be differentially effective across subpopulations, including levels of resting LVEF,
age, medications, treatment site, gender, ethnicity, and pretreatment levels of stress.
Treatment effect on clinical outcomes—The Cox proportional hazards model will be
used to evaluate the effect of treatment on the composite endpoint of death or first cardiac-
related hospitalization. Patients who have not experienced an event before the follow-up
period has ended will be coded as censored at the time of last-contact. In addition to
examining standard regression assumptions, assumptions specific to the Cox model will be
assessed using techniques suggested by Shoenfeld.62 We will use Harrell's Design and
Hmisc libraries63 in the R software package (http://cran.r project.org) to conduct these
analyses. As was the case for the analysis of stress variables and risk biomarkers, we also
will add propensity adjustment to this analysis, and also will explore the extent to which the
treatment might be differentially effective across subpopulations using a series of models
that include treatment by subgroup interaction terms.
Analysis of mediators—The general approach to the statistical test of mediation is as
follows. We will evaluate a) the extent to which the stress variables mediate the relation
between treatment and risk biomarkers, and b) the mediating role that risk biomarkers and
the stress variables have between treatment and clinical event outcomes. These analyses
proceed by establishing first that a) the treatment has a meaningful effect on the outcome of
interest; b) the treatment is related to the mediator; and c) the mediator is related to the
outcome. In a final step, the mediator and treatment indicator are included simultaneously as
predictors of the outcome of interest.
CONCLUSIONS
To date, previous studies employing stress management approaches in CHD patients have
had important methodological limitations and several of the larger RCTs have failed to
demonstrate a benefit for SMT over usual care.22,37 These limitations have raised questions
about the value of SMT for patients with CHD. The selection of appropriate endpoints for
SMT continues to be a challenge as “hard” clinical endpoints require large sample sizes that
are burdensome to conduct and expensive. The use of intermediate pathophysiologic
endpoints presents a unique way to study the benefits of SMT on meaningful biomedical
outcomes that have been shown to be independently associated with increased risk and could
provide a basis for larger RCTs. The ENHANCED study will begin patient recruitment in
January 2010 and is scheduled to conclude enrollment in May 2014.
CONDENSED ABSTRACT
Enhancing Standard Cardiac Rehabilitation with Stress Management Training in Patients
with Heart Disease (ENHANCED) is a randomized clinical trial examining the added
value of stress management training (SMT) in the context of cardiac rehabilitation (CR).
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Participants undergo evaluations of stress and cardiovascular biomarkers. Results have
implications for including SMT within standard CR.
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The proposed investigation involves (1) a careful screening of potential participants; (2) a
thorough pre-treatment assessment of stress and biomarkers of risk; (3) a randomized
clinical trial of cardiac rehabilitation alone and Stress Management Trteatment (SMT)-
enhanced cardiac rehabilitation; (4) post-treatment assessment of the impact of the 3-month
intervention on cardiovascular biomarkers and quality of life; and (5) follow-up in which we
plan to follow all participants for at least 6 months and up to 4 years (median 30 months) to
assess clinical events including myocardial infarction, death, and cardiac-related
hospitalizations.
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TABLE 1
MEASURES OF STRESS AND HEALTH BEHAVIORS
General Health
Questionnaire40
A 34-item self-report measure that assesses patient




A 21-item self-report inventory of depression that has been




An anxiety measure consisting of 2 separate self-report




A 50-item true or false questionnaire derived from the




Patients reconstruct their medication regimen over the past
7 days, including the names of medications, dosages,
indications, and self-report of missed doses; also asks
several questions about barriers to adherence such as
memory difficulty or side effects.
7-day retrospective Food
Frequency Questionnaire45
Patients are asked to recall typical consumption of various
food groups over a 1 week period.
CHAMPS Activities
Questionnaire46
A comprehensive self-report measure of exercise activity
for use among sedentary older adults.
Brief Cope Questionnaire47 An instrument assessing the use of coping strategies for use
among healthy adults as well as adults with chronic illness.
Dysfunctional Attitudes
Scale48
An additional indicator of participant use of negative
cognitive processing in approaching life problems.
Perceived Social Support
Scale49
A measure assessing perceived levels of social support.
J Cardiopulm Rehabil Prev. Author manuscript; available in PMC 2011 March 1.
